Recommendations for early detection of cancer during covid-19 pandemic in 2021

Authors

Keywords:

Coronavirus Infections, Cancer, Epidemiology, Early Detection of Cancer

Abstract

With the Coronavirus disease (COVID-19) pandemic, elective care, including cancer screening, was interrupted in most countries in order to prioritize urgent care and reduce the risk of disseminating the new Coronavirus (SARS-CoV-2) in health care services. 

Downloads

Download data is not yet available.

Author Biographies

Arn Migowski, Instituto Nacional de Câncer (INCA)

MD from the State University of Rio de Janeiro (UERJ); specialization in Public Health (IESC-UFRJ); Masters in Epidemiology (IMS-UERJ) and Doctorate in Public Health (IMS-UERJ). Chief of the Division of Cancer Early Detection and Network Organizational Support of the Brazilian National Cancer Institute (INCA). Researcher at the National Institute of Cardiology (INC). 

Flávia de Miranda Corrêa, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)

MD from the Federal University of Rio de Janeiro; residency in Gynecology and Obstetrics (HU-UFRJ); Master’s and Doctorate in Woman’s and Child’s Health (IFF/Fiocruz); MBA in Economics and Health Technology Assessment (HAOC-FIPE). Adjunct researcher and substitute Chief of the Division of Cancer Early Detection and Network Organizational Support of the Brazilian National Cancer Institute (INCA). Email: fcorrea@inca.gov.br

Downloads

Published

2021-06-23

Issue

Vol. 23 No. 1 (2020)

Section

Tribuna